Showing results (711-720 of 2,378) with videos related to
Sort By:
Pageof 238
Current Opinion in Pharmacology|September 4, 2021
Plant-based vaccine research development against viral diseases with emphasis on Ebola virus disease: A review studySatyajit Tripathy, Barsha Dassarma, Manojit Bhattacharya, et al.Current Opinion in Pharmacology|August 31, 2021
Therapeutics development for Ebola virus disease: A recent scenarioChiranjib ChakrabortyCurrent Opinion in Pharmacology|September 2, 2021
Nonsteroidal mineralcorticoid receptor antagonists: Novel therapeutic implication in the management of patients with type 2 diabetesE A Greco, A Feraco, V Marzolla, et al.Current Opinion in Pharmacology|June 9, 2015
CSF-1/CSF-1R targeting agents in clinical development for cancer therapyCarola H Ries, Sabine Hoves, Michael A Cannarile, et al.Current Opinion in Pharmacology|June 29, 2015
Drugging PI3K in cancer: refining targets and therapeutic strategiesTimothy A Yap, Lynn Bjerke, Paul A Clarke, et al.Current Opinion in Pharmacology|June 30, 2015
The global challenge of new classes of antibacterial agents: an industry perspectivePrabhavathi FernandesCurrent Opinion in Pharmacology|July 16, 2016
Guiding lead optimization with GPCR structure modeling and molecular dynamicsAlexander Heifetz, Tim James, Inaki Morao, et al.Current Opinion in Pharmacology|September 9, 2021
A double-edged sword: The Kelch-like ECH-associated protein 1-nuclear factor erythroid-derived 2-related factor 2-antioxidant response element pathway targeted pharmacological modulation in nonalcoholic fatty liver diseaseYong-Lun Wang, Jiao Wu, Rui-Xi Li, et al.Current Opinion in Pharmacology|June 2, 2020
Exercise and browning of white adipose tissue - a translational perspectiveMai Charlotte Krogh Severinsen, Camilla Schéele, Bente Klarlund PedersenCurrent Opinion in Pharmacology|June 10, 2015
Advances in the development of histone lysine demethylase inhibitorsTamara Maes, Elena Carceller, Jordi Salas, et al.Pageof 238